Pharma Technology Focus is now published monthly and free for the iPad. Download our app to read the latest issue and browse our back issues for free.
Go deeper with GlobalData
New data shows that we know nowhere near enough about the true scope of falsified medicines, which pose an urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis. We review the latest research into the issue and ask what the industry can do about it.
A new breakthrough in telomere research could raise the prospect of a cancer-predicting blood test. We find out how the discovery of a vital long-term telomere pattern could affect cancer diagnostics and whether there could be unintended implications for health insurance.
We also take a look at a range of new hearing loss treatments set to come to market, explore the potential of biosimilars in offering cheaper alternatives to some of the most expensive drugs on the market and the regulatory hurdles that need to be overcome, and find out what’s new
in pharmaceutical packaging.
Read the issue for free on your iPad through our app, or if you’re on a desktop computer you can also read it in our web viewer.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIn this issue
Tip of the Iceberg
New data shows that we know nowhere near enough about the true scope of the falsified medicines problem. Elly Earls finds out what the industry can do to gain more data and act upon it.
Read the article.
Safe, Simple & Secure
From new anti-tamper systems and child-proof opening mechanisms to smart tracking technologies, Abi Millar profiles innovations in pharma packaging and the requirements driving them.
Read the article.
Eyes on Novartis
Novartis stands accused of trying to sabotage research into a rival eye drug in the UK and faces suspension in Japan after a series of trial data scandals. Julian Turner asks GlobalData analyst Shaan Thakerar for his take on the controversy.
Read the article.
The Telling Telomere
A new breakthrough in telomere research could raise the prospect of a cancer-predicting blood test. Chris Lo finds out how the discovery of a vital long-term telomere pattern could affect cancer diagnostics and whether there would be unintended implications for health insurance.
Read the article.
A Rocky Road Ahead
Biosimilars could save patients and health systems billions, but regulatory and market obstacles stand in the way of this promising field achieving its potential. Chris Lo finds out more.
Read the article.
Listen Up
Hearing loss and tinnitus affect millions of people, but until recently there were no drug treatments being developed for either condition. Elly Earls finds out why things are changing.
Read the article.
Next issue preview
South Africa is looking to follow China’s lead by building state-owned pharma manufacturing capacity to help meet the needs of its health system with less reliance on foreign imports, but it has a bumpy road ahead. We find out how the country aims to reach its goal.
We also investigate the details of Teva’s Mylan takeover bid and what it could mean for the generics market, check in on the progress of the US 21st Century Cures Act through the legislative process, and speak to Clinigen about carving out a niche in the ethical supply of unlicensed medicines.
Moreover, we ask why the pharma industry is showing a growing interest in the potential of gamification – an approach that turns taking medicine into a game-like experience though the use of smartphone apps, and hear from IAOCR why CROs need to rethink their recruitment strategies as demand for resources in clinical research grows.
Digital magazine FAQ
You can read Pharma Technology Focus for free on the iPad. Download our app from the App Store to read the latest issue and browse the back issues in our archive. Sign up for a free subscription in the app and never miss a new issue.
You can also continue to read the desktop version for free on our web viewer. (Browser compatibility: The web viewer works in the latest two version of Chrome, Firefox and Safari, as well as in Internet Explorer 9 and 10. Some features may not be compatible with older browser versions.)
